The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2023 | The current state-of-the-art in PV and future outlooks
Francesco Passamonti, MD, University of Insubria, Varese, Italy, briefly discusses the current state-of-the-art in polycythemia vera (PV), highlighting the value of agents including ropeginterferon alfa-2b and ruxolitinib. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
